Updated results from a phase I trial of CAR-T cell therapy for r/rMM
Updated results from a phase I trial of CAR-T cell therapy for r/rMM
Fatigue at baseline predicts shorter survival in older patients with a haematological malignancy
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma
Updates from Myeloma XI trial
Ribosomal lesions promote oncogenic mutagenesis
Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma
Interim results of RELEVANCE trial in follicular lymphoma
Disease control in advanced Hodgkin lymphoma
Improved OS with obinutuzumab in the CLL11 study
Rituximab in combination therapies for FL: Interim results
Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results
Mapping 3D genome dynamics in B cells